Subset of breast cancer patients found to benefit from neratinib in latest trial
Subset of breast cancer patients found to benefit from neratinib in latest trial
"Exciting" implications of bemacyclib study in the treatment of breast cancer
Immunotherapy in melanoma
Impact of the liver environment upon the efficacy of induction therapy
Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies
Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor
Effective use of ibrutinib in the treatment of ABC lymphoma tumours
Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475
Benefits found for lung cancer patients with high levels of PD-L1 with MK-3475 treatment
Role of genomics in assessing risk, especially in ovarian cancer
The relationship between obesity and cancer, and other dietary factors
New antibody-drug conjugate shows early promise against all forms of melanoma